Literature DB >> 7508349

Functional heterogeneity of mast cells isolated from different microenvironments within nasal polyp tissue.

S Finotto1, J Dolovich, J A Denburg, M Jordana, J S Marshall.   

Abstract

Nasal polyposis is a chronic inflammatory condition of the upper airways characterized by infiltration of activated inflammatory cells, including mast cells, both in the epithelium and in the stroma. The aim of this work was to study human mast cells derived from two different anatomical sites within the same nasal polyp tissue. To this end, we isolated two distinct mast cell populations, one from the epithelial and the other from the stromal layers of individual human nasal polyp tissues. We examined the mediator content of the two mast cell populations and found that stromal mast cells had a significantly higher content of tryptase compared with the epithelial mast cells from the same tissue. In addition, mast cells from the stromal compartment, but not those from the epithelium, released a significant amount of histamine after anti-IgE stimulation. By contrast, both populations released over 50% of the total histamine after non-specific stimuli (A23187 10(-6) M). The content of mediators and the response to immunological activation were not significantly altered in patients receiving topical steroid therapy. It remains to be determined if the observed differences are the result of an intrinsic characteristic of the mast cell populations localized to separate tissue compartments, or reflect a different in vivo exposure to stimuli such as antigens, or different surrounding structural or infiltrating cells. In conclusion, these data provide evidence of functional heterogeneity and differences in mediator content between mast cell subpopulations from a single human tissue. The failure of release of epithelial mast cell mediators from an immunologic stimulus may have implications concerning acute effects of antigen exposure in nasal polyposis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7508349      PMCID: PMC1534920          DOI: 10.1111/j.1365-2249.1994.tb06535.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Histochemical and immunohistochemical characteristics of mast cells in nasal polyps.

Authors:  S Kawabori; J A Denburg; L B Schwartz; A A Irani; D Wong; G Jordana; S Evans; J Dolovich
Journal:  Am J Respir Cell Mol Biol       Date:  1992-01       Impact factor: 6.914

2.  Human mast cells recovered by bronchoalveolar lavage: their morphology, histamine release and the effects of sodium cromoglycate.

Authors:  K C Flint; K B Leung; F L Pearce; B N Hudspith; J Brostoff; N M Johnson
Journal:  Clin Sci (Lond)       Date:  1985-04       Impact factor: 6.124

3.  Human intestinal mucosal mast cells: evaluation of fixation and staining techniques.

Authors:  S Strobel; H R Miller; A Ferguson
Journal:  J Clin Pathol       Date:  1981-08       Impact factor: 3.411

4.  Characterization of histamine secretion from mechanically dispersed human lung mast cells: effects of anti-IgE, calcium ionophore A23187, compound 48/80, and basic polypeptides.

Authors:  M K Church; G J Pao; S T Holgate
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

Review 5.  Mast cell heterogeneity: evidence and implications.

Authors:  K E Barrett; D D Metcalfe
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

6.  Fine structure of nasal polyps.

Authors:  N Cauna; G W Manzetti; K H Hinderer; E W Swanson
Journal:  Ann Otol Rhinol Laryngol       Date:  1972-02       Impact factor: 1.547

7.  Nasal polyps in asthma and rhinitis. A review of 6,037 patients.

Authors:  G A Settipane; F H Chafee
Journal:  J Allergy Clin Immunol       Date:  1977-01       Impact factor: 10.793

8.  IgE-mediated release of histamine from human cutaneous mast cells.

Authors:  M D Tharp; R T Suvunrungsi; T J Sullivan
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

9.  Human lung mast cells: purification and characterization.

Authors:  E S Schulman; D W MacGlashan; S P Peters; R P Schleimer; H H Newball; L M Lichtenstein
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

10.  Tryptase from human pulmonary mast cells. Purification and characterization.

Authors:  L B Schwartz; R A Lewis; K F Austen
Journal:  J Biol Chem       Date:  1981-11-25       Impact factor: 5.157

View more
  10 in total

1.  Expression of oestrogen and progesterone receptors by mast cells alone, but not lymphocytes, macrophages or other immune cells in human upper airways.

Authors:  X J Zhao; G McKerr; Z Dong; C A Higgins; J Carson; Z Q Yang; B M Hannigan
Journal:  Thorax       Date:  2001-03       Impact factor: 9.139

2.  Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma.

Authors:  Z Qu; J M Liebler; M R Powers; T Galey; P Ahmadi; X N Huang; J C Ansel; J H Butterfield; S R Planck; J T Rosenbaum
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

3.  Chemokine (C-C Motif) receptor 1 is required for efficient recruitment of neutrophils during respiratory infection with modified vaccinia virus Ankara.

Authors:  Philip J R Price; Bruno Luckow; Lino E Torres-Domínguez; Christine Brandmüller; Julia Zorn; Carsten J Kirschning; Gerd Sutter; Michael H Lehmann
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

4.  Mast cell quantitation in non- neoplastic polypoidal nasal lesions.

Authors:  Vijaya V Mysorekar; Chitralekha P Dandekar; Saraswati G Rao
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2004-04

5.  Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation.

Authors:  Daniel F Dwyer; Jose Ordovas-Montanes; Samuel J Allon; Kathleen M Buchheit; Marko Vukovic; Tahereh Derakhshan; Chunli Feng; Juying Lai; Travis K Hughes; Sarah K Nyquist; Matthew P Giannetti; Bonnie Berger; Neil Bhattacharyya; Rachel E Roditi; Howard R Katz; Martijn C Nawijn; Marijn Berg; Maarten van den Berge; Tanya M Laidlaw; Alex K Shalek; Nora A Barrett; Joshua A Boyce
Journal:  Sci Immunol       Date:  2021-02-26

6.  Primary human airway epithelial cell-dependent inhibition of human lung mast cell degranulation.

Authors:  Neil Martin; Andrew Ruddick; Greer K Arthur; Heidi Wan; Lucy Woodman; Christopher E Brightling; Don J L Jones; Ian D Pavord; Peter Bradding
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

Review 7.  Pathogenesis of nasal polyps: an update.

Authors:  Rafal Pawliczak; Anna Lewandowska-Polak; Marek L Kowalski
Journal:  Curr Allergy Asthma Rep       Date:  2005-11       Impact factor: 4.919

8.  Association of Mast Cell Burden and TIM-3 Expression with Recalcitrant Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Michael A Belsky; Erica Corredera; Hridesh Banerjee; John Moore; Li Wang; Lawrence P Kane; Stella E Lee
Journal:  Ann Otol Rhinol Laryngol       Date:  2021-02-12       Impact factor: 1.973

9.  Enhanced release of IgE-dependent early phase mediators from nasal polyp tissue.

Authors:  Joke Patou; Gabriele Holtappels; Karen Affleck; Philippe Gevaert; Claudina Perez-Novo; Paul Van Cauwenberge; Claus Bachert
Journal:  J Inflamm (Lond)       Date:  2009-04-20       Impact factor: 4.981

Review 10.  The Unresolved Role of Interferon-λ in Asthma Bronchiale.

Authors:  Nina Sopel; Andreas Pflaum; Julia Kölle; Susetta Finotto
Journal:  Front Immunol       Date:  2017-08-15       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.